August 14: The FDA granted an additional approval to Avastin in combination with paclitaxel and cisplatin or paclitaxel and topotecan for the treatment of advanced cervical cancer. The Genentech, Inc. infusible has FDA approval for four other tumor types: metastatic colorectal cancer, advanced nonsquamous non-small cell lung cancer, metastatic renal cell carcinoma and recurrent glioblastoma. […]
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.